Palo Alto Investors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.18M | Hold |
|
|||||
|
2023
Q3 | $1.21M | Sell |
|
|||||
|
2023
Q2 | $2.14M | Sell |
|
|||||
|
2023
Q1 | $3.28M | Sell |
|
|||||
|
2022
Q4 | $8.04M | Sell |
|
|||||
|
2022
Q3 | $21.4M | Sell |
|
|||||
|
2022
Q2 | $27.2M | Hold |
|
|||||
|
2022
Q1 | $28.2M | Sell |
|
|||||
|
2021
Q4 | $44.5M | Sell |
|
|||||
|
2021
Q3 | $65M | Hold |
|
|||||
|
2021
Q2 | $81.6M | Hold |
|
|||||
|
2021
Q1 | $57M | Sell |
|
|||||
|
2020
Q4 | $55.6M | Buy |
|
|||||
|
2020
Q3 | $40.3M | Buy |
|
|||||
|
2020
Q2 | $47.1M | Sell |
|
|||||
|
2020
Q1 | $42.8M | Sell |
|
|||||
|
2019
Q4 | $74.3M | Sell |
|
|||||
|
2019
Q3 | $60.8M | Sell |
|
|||||
|
2019
Q2 | $71.2M | Hold |
|
|||||
|
2019
Q1 | $93M | Buy |
|
|||||
|
2018
Q4 | $109M | Hold |
|
|||||
|
2018
Q3 | $95.4M | Hold |
|
|||||
|
2018
Q2 | $79.2M | Hold |
|
|||||
|
2018
Q1 | $70M | Hold |
|
|||||
|
2017
Q4 | $63.2M | Hold |
|
|||||
|
2017
Q3 | $74.4M | Sell |
|
|||||
|
2017
Q2 | $68.5M | Hold |
|
|||||
|
2017
Q1 | $58.8M | Hold |
|
|||||
|
2016
Q4 | $67M | Buy |
|
|||||
|
2016
Q3 | $68.4M | Sell |
|
|||||
|
2016
Q2 | $47.3M | Buy |
|
|||||
|
2016
Q1 | $33.7M | Hold |
|
|||||
|
2015
Q4 | $37.5M | Buy |
|
|||||
|
2015
Q3 | $45.1M | Buy |
|
|||||
|
2015
Q2 | $49.5M | Buy |
|
|||||
|
2015
Q1 | $35.4M | Buy |
|
|||||
|
2014
Q4 | $54.2M | Buy |
|
|||||
|
2014
Q3 | $34.1M | Buy |
|
|||||
|
2014
Q2 | $52.4M | Buy |
|
|||||
|
2014
Q1 | $52.3M | Sell |
|
|||||
|
2013
Q4 | $40.2M | Buy |
|
|||||
|
2013
Q3 | $31.8M | Buy |
|
|||||
|
2013
Q2 | $19.2M | Buy |
|